Four patients had serum sickness-like reactions during treatment with
cefprozil, a new cephalosporin. Two patients had had previous mild rea
ctions associated with cephalosporin therapy. It remains uncertain whe
ther ceprozil-associated serum sickness-like reaction represents a uni
que or a class-related adverse drug reaction.